Literature DB >> 9628513

A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis.

C S Derkay1, D J Malis, G Zalzal, B J Wiatrak, H K Kashima, M D Coltrera.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9628513     DOI： 10.1097/00005537-199806000-00026

Source DB:  PubMed          Journal:  Laryngoscope        ISSN： 0023-852X            Impact factor:   3.325


× No keyword cloud information.
  29 in total

1.  Otolaryngology-head and neck surgery at Johns Hopkins: The first 100 years (1914-2014).

Authors:  Howard W Francis; Ira Papel; Ioan Lina; Wayne Koch; David Tunkel; Paul Fuchs; Sandra Lin; David Kennedy; Robert Ruben; Fred Linthicum; Bernard Marsh; Simon Best; John Carey; Andrew Lane; Patrick Byrne; Paul Flint; David W Eisele
Journal:  Laryngoscope       Date:  2015-08-22       Impact factor: 3.325

2.  Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir--a prospective study.

Authors:  Frederik G Dikkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-22       Impact factor: 2.503

3.  Intralesional Cidofovir application in recurrent laryngeal papillomatosis.

Authors:  Annett Pudszuhn; Cornelia Welzel; Marc Bloching; Kerstin Neumann
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-13       Impact factor: 2.503

4.  Recurrent respiratory pappillomatosis: national registry.

Authors:  Anupam Mishra; D B Singh; Veerendra Verma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-03-29

5.  The PD-1 and PD-L1 pathway in recurrent respiratory papillomatosis.

Authors:  Julie Ahn; Justin A Bishop; Richard B S Roden; Clint T Allen; Simon R A Best
Journal:  Laryngoscope       Date:  2017-09-22       Impact factor: 3.325

Review 6.  [Current therapeutic options for recurrent respiratory papillomatosis].

Authors:  K Huber; H Sadick; K Götte
Journal:  HNO       Date:  2005-11       Impact factor: 1.284

Review 7.  Adjuvant antiviral therapy for recurrent respiratory papillomatosis.

Authors:  Neil K Chadha; Adrian James
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

8.  Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis.

Authors:  Irena Hočevar-Boltežar; Mojca Matičič; Maja Sereg-Bahar; Nina Gale; Mario Poljak; Boštjan Kocjan; Miha Zargi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-26       Impact factor: 2.503

9.  HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis.

Authors:  Colin M Gelder; O Martin Williams; Keith W Hart; Siôn Wall; Gareth Williams; Duncan Ingrams; Peter Bull; Mike Bunce; Ken Welsh; Sara E F Marshall; Leszek Borysiewicz
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Genomic differences in the background of different severity in juvenile-onset respiratory papillomatoses associated with human papillomavirus type 11.

Authors:  Tamás Gáll; Andrea Kis; Tímea Zsófia Tatár; Gábor Kardos; Lajos Gergely; Krisztina Szarka
Journal:  Med Microbiol Immunol       Date:  2013-05-07       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.